You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Viral Infections
 •Dermatologic Disorders, Other
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic

Necrolytic Acral Erythema Associated With Hepatitis C

Effective Treatment With Interferon Alfa and Zinc

Vikram J. Khanna, MD; Sherry Shieh, MD; Jaye Benjamin, MD; Stephen Somach, MD; M. Tarif Zaim, MD; William Dorner, Jr, MD; Martin Shill, MD; Gary S. Wood, MD

Arch Dermatol. 2000;136:755-757.

Background  Necrolytic acral erythema is a recently described necrolytic erythema that is unique in its exclusive acral location and strong association with hepatitis C.

Observation  We report the first case of necrolytic acral erythema in the United States. The patient is a 43-year-old black woman who presented with a 4-year history of tender, flaccid blisters localized to the dorsal aspect of her feet. Serum zinc and glucagon levels were normal. Serum antibodies were positive for hepatitis C, and a liver biopsy specimen showed chronic hepatitis. She was successfully treated with interferon alfa-2b and zinc. We review all previously reported cases.

Conclusions  Necrolytic acral erythema is a distinct entity. In a review of the literature, most patients were between 35 and 55 years of age, although 1 patient was 12 years old. Five of 8 patients were female. Four of 7 patients described previously were treated with variable success using oral zinc sulfate and amino acids, whereas 2 were successfully treated with interferon alfa. All patients were infected with hepatitis C. Necrolytic acral erythema appears to be a skin disorder linked to infection with hepatitis C virus that responds to treatment with interferon alfa and oral zinc.


From the Departments of Dermatology (Drs Khanna, Benjamin, and Wood), Internal Medicine (Dr Shieh), and Pathology (Drs Zaim and Wood), General Medical Sciences (Oncology) (Dr Wood), Case Western Reserve University, University Hospitals of Cleveland, Louis Stokes Cleveland Veterans Affairs Medical Center, Department of Dermatology, Metro Health Medical Center, Campus of Case Western Reserve University (Dr Somach), Cleveland, Ohio; and Division of Gastroenterology, Akron General Medical Center, Akron, Ohio (Dr Shill). Dr Dorner is retired from private practice in Akron, Ohio.


RELATED ARTICLE

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2000;136(6):811-812.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Necrolytic Acral Erythema: A Patient From the United States Successfully Treated With Oral Zinc
Abdallah et al.
Arch Dermatol 2005;141:85-87.
ABSTRACT | FULL TEXT  

Striaelike Epidermal Distension: A Newly Recognized Cutaneous Manifestation in Acute Leg Edema
Ishiguro and Kawashima
Arch Dermatol 2002;138:641-642.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.